2-Hydroxy-5-[(6-methyl-5-phenylthieno[2,3-d]pyrimidin-4-yl)amino]benzoic acid

ID: ALA3793178

PubChem CID: 21011787

Max Phase: Preclinical

Molecular Formula: C20H15N3O3S

Molecular Weight: 377.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1sc2ncnc(Nc3ccc(O)c(C(=O)O)c3)c2c1-c1ccccc1

Standard InChI:  InChI=1S/C20H15N3O3S/c1-11-16(12-5-3-2-4-6-12)17-18(21-10-22-19(17)27-11)23-13-7-8-15(24)14(9-13)20(25)26/h2-10,24H,1H3,(H,25,26)(H,21,22,23)

Standard InChI Key:  HLSKFYVKASGQAP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -1.0028    1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9971   -3.0138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2935   -3.7700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2901   -5.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5873   -6.0231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8881   -5.2761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8917   -3.7761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5944   -3.0231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7889    0.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1852   -2.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6221   -3.0405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9838   -4.4963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9039   -5.5373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4624   -5.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1007   -3.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5807   -7.5239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6174   -8.1281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5392   -8.1199    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9259   -5.8786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6 11  1  0
 10  7  1  0
  7  5  1  0
  4  8  1  0
  8  9  1  0
 10 11  2  0
  9 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16  9  1  0
 10 17  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 11 18  1  0
 24 25  1  0
 24 26  2  0
 13 24  1  0
 14 27  1  0
M  END

Associated Targets(Human)

CSNK2B Tbio Casein kinase II (1406 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.43Molecular Weight (Monoisotopic): 377.0834AlogP: 4.81#Rotatable Bonds: 4
Polar Surface Area: 95.34Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.60CX Basic pKa: 2.94CX LogP: 5.15CX LogD: 2.23
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.44Np Likeness Score: -1.19

References

1. Ostrynska OV, Balanda AO, Bdzhola VG, Golub AG, Kotey IM, Kukharenko OP, Gryshchenko AA, Briukhovetska NV, Yarmoluk SM..  (2016)  Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.,  115  [PMID:27017545] [10.1016/j.ejmech.2016.03.004]

Source